Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
R. Chambers (London, United Kingdom). Coagulation and fibrinolysis in lung remodelling and repair. Annual Congress 2006 - PG15 - Remodelling and repair in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Role of coagulation cascade proteases and lung repair and fibrosis Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease Year: 2003 Role of coagulation cascade proteases in lung repair and fibrosis Source: Eur Respir J 2003; 22: 33S-35S Year: 2003 Inhibition of fibrinolysis stimulates alveolar wound repair in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 586s Year: 2003 Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation Source: Eur Respir J 2007; 30: 423-428 Year: 2007 Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling Source: Eur Respir Rev 2008; 17: 130-137 Year: 2008 Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Coagulation in lung fibrosis: multiple pathways leading to fibroblast activation Source: Annual Congress 2012 - PG11 Pulmonary fibrosis Year: 2012 Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007 Intraalveolar levels of tenascin C and thrombin-activatable fibrinolysis inhibitor in interstitial lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 Function of the myofibroblast during tissue repair Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Angiogenesis and coagulation in the development of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 608s Year: 2007 Pulmonary vascular injury, repair and remodelling in COPD patients Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Clinical evaluation of angiogenesis and coagulation in pulmonary sarcoidosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005 Serotonin and pulmonary vascular remodelling Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Increased intraalveolar levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with interstitial lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002